Cargando…

Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat

BACKGROUND: Tesamorelin, a synthetic analog of human growth hormone-releasing factor, decreases visceral adipose tissue (VAT) in human immunodeficiency virus (HIV)-infected patients with lipodystrophy. OBJECTIVES: 1) To evaluate the utility of patient characteristics and validated disease-risk score...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mangili, Alexandra, Falutz, Julian, Mamputu, Jean-Claude, Stepanians, Miganush, Hayward, Brooke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601733/ https://www.ncbi.nlm.nih.gov/pubmed/26457580 http://dx.doi.org/10.1371/journal.pone.0140358

Ejemplares similares

Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial
por: Clemmons, David R., et al.
Publicado: (2017)

Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
por: Bedimo, Roger
Publicado: (2011)

Tesamorelin: A hope for ART-induced lipodystrophy
por: Patel, Akash, et al.
Publicado: (2011)

1499. Tesamorelin Reduces Visceral Adipose Tissue and Liver Fat in INSTI-Treated Persons with HIV
por: McLaughlin, Taryn, et al.
Publicado: (2023)

Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD
por: Fourman, Lindsay T., et al.
Publicado: (2020)

Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial
por: Rahman, Farah, et al.
Publicado: (2022)

Neuropsychological endpoints for clinical trials in methylmalonic acidemia and propionic acidemia: A pilot study
por: Chapman, Kimberly A., et al.
Publicado: (2023)

935. Effect of Tesamorelin in People with HIV with and without Dorsocervical Fat: Post Hoc Analysis of Phase III Double Blind Placebo Control Trial
por: Rahman, Farah, et al.
Publicado: (2020)

Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach
por: Fourman, Lindsay T., et al.
Publicado: (2021)

The Effects of Gonadotropin-Releasing Hormone Analog and a Combination of Gonadotropin-Releasing Hormone Analog and Recombinant Human Growth Hormone on Adult Height in Girls with Early Puberty
por: Hajzadeh, Ghodsieh, et al.
Publicado: (2019)

Gonadotropin-releasing hormone analogs: Understanding advantages and limitations
por: Kumar, Pratap, et al.
Publicado: (2014)

Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs
por: Huerta-Reyes, Maira, et al.
Publicado: (2019)

THU194 Growth Pattern And Related Predictors Of Gonadotropin-releasing Hormone Analog Treatment In Girls With Precocious Puberty
por: Ouyang, Lixue, et al.
Publicado: (2023)

Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation
por: Fleming, Richard
Publicado: (2022)

Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice
por: Recinella, Lucia, et al.
Publicado: (2021)

Adjuvant gonadotropin releasing hormone analog in gonadotoxic chemotherapy for preservation of fertility
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)

Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice
por: Recinella, Lucia, et al.
Publicado: (2020)

Efficacy of Combined Levonorgestrel-Releasing Intrauterine System with Gonadotropin-Releasing Hormone Analog for the Treatment of Adenomyosis
por: Zhang, Peihai, et al.
Publicado: (2013)

Excess Early Postnatal Weight Gain Leads to Increased Abdominal Fat in Young Children
por: Evelein, Annemieke M. V., et al.
Publicado: (2012)

Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes
por: He, Yingna, et al.
Publicado: (2010)

A conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancer
por: Zhu, Shengsheng, et al.
Publicado: (2016)

Publisher Correction: Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice
por: Recinella, Lucia, et al.
Publicado: (2020)

Excess abdominal fat is associated with cutaneous allodynia in individuals with migraine: a prospective cohort study
por: Mínguez-Olaondo, Ane, et al.
Publicado: (2020)

Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
por: Kim, Eun Young
Publicado: (2015)

Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States
por: Popovic, Jadranka, et al.
Publicado: (2022)

Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment
por: Gui, Ting, et al.
Publicado: (2015)

Clinical and Laboratory Parameters of Gonadotropin-Releasing Hormone Analog Treatment Effectiveness in Children with Precocious Puberty
por: Fujita, Lívia Grimaldi Abud, et al.
Publicado: (2019)

Effect of tamoxifen with or without gonadotropin-releasing hormone analog on DXA values in women with breast cancer
por: Kim, Eun Heui, et al.
Publicado: (2021)

A Case of Nonalcoholic Steatohepatitis in Central Precocious Puberty Aggravated by Gonadotropin-releasing Hormone Analog
por: Sasaki, Yoshiaki, et al.
Publicado: (2020)

Abdominal Fat and Metabolic Health Markers but Not PNPLA3 Genotype Predicts Liver Fat Accumulation in Response to Excess Intake of Energy and Saturated Fat in Healthy Individuals
por: Rosqvist, Fredrik, et al.
Publicado: (2020)

Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone
por: Jaszberenyi, Miklos, et al.
Publicado: (2013)

Design and Exploratory Neuropharmacological Evaluation of Novel Thyrotropin-Releasing Hormone Analogs and Their Brain-Targeting Bioprecursor Prodrugs
por: Prokai-Tatrai, Katalin, et al.
Publicado: (2013)

Are thyrotropin‐releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid‐induced respiratory depression?
por: Algera, Marieke Hyke, et al.
Publicado: (2022)

Thyrotropin-releasing hormone analog as a stable upper airway-preferring respiratory stimulant with arousal properties
por: Liu, Wen-Ying, et al.
Publicado: (2022)

Excess of Fat in the Artificial Feeding of Infants
Publicado: (1905)

CRC handbook of neurohypophyseal hormone analogs

Adrenocorticotropic hormone analog use for podocytopathies
por: Filippone, Edward J, et al.
Publicado: (2016)

Intra-abdominal fat accumulation is an important predictor of metabolic syndrome in young adults
por: Kobayashi, Masakazu, et al.
Publicado: (2020)

In vivo effect of an luteinizing hormone-releasing hormone analog on vascular endothelial growth factor and epidermal growth factor receptor expression in mammary tumors
por: Flores, Ana Isabel, et al.
Publicado: (2009)

Effect of Zoledronic Acid on Bone Mineral Density in Men with Prostate Cancer Receiving Gonadotropin-Releasing Hormone Analog
por: Kapoor, Anoop, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9t77dvc117ah4egnbp2ont2kcf